CRELD2

Gene mapping, alternate splicing, and comparative genomic identification of the promoter region

Cheryl Maslen, Darcie Babcock, Jennifer K. Redig, Katannya Kapeli, Yassmine M. Akkari, Susan Olson

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

CRELD2 is the second member of the CRELD family of proteins. The only other CRELD family member, encoded by CRELD1, is also known as the AVSD2 gene as mutations in CRELD1 are associated with cardiac atrioventricular septal defects (AVSD). Like CRELD1, CRELD2 is ubiquitously expressed during development and by mature tissues. Recently, a specific CRELD2 isoform (CRELD2β) was implicated as a regulator of α4β2 nicotinic acetylcholine receptor expression, suggesting that the CRELD family has widely diverse biological roles in both developmental events and subsequent cell function. Here we report additional characterization of CRELD2, which was undertaken to further our understanding of this important family. Mapping of CRELD2 by FISH shows that it maps to 22q13 rather than the GenBank reported locus of 22p13. Comparative genomic analysis of upstream sequences shows a discrete region that is highly conserved among diverse species with hallmark features indicative of a promoter region. Functional analysis demonstrates that this region has promoter activity. Consistent with widespread expression of CRELD2, this region is GC-rich and lacks a TATA box. Overall, the highest levels of CRELD2 expression occur in adult endocrine tissues. However, alternative splicing of CRELD2 is extensive with positive identification of several splice variants expressed by most normal fetal and adult tissues. Confirmed splice variants encode 5 different CRELD2 isoforms that differ significantly in composition indicating that CRELD2 function is varied and as yet poorly understood.

Original languageEnglish (US)
Pages (from-to)111-120
Number of pages10
JournalGene
Volume382
DOIs
StatePublished - Nov 1 2006

Fingerprint

Chromosome Mapping
Alternative Splicing
Genetic Promoter Regions
Heart Septal Defects
Protein Isoforms
GC Rich Sequence
TATA Box
Nucleic Acid Databases
Nicotinic Receptors
Sequence Analysis
Fetus
Mutation
Genes
Proteins

Keywords

  • AVSD2
  • Congenital heart defects
  • CRELD1
  • Endocrine system
  • Nicotinic acetylcholine receptor

ASJC Scopus subject areas

  • Genetics

Cite this

CRELD2 : Gene mapping, alternate splicing, and comparative genomic identification of the promoter region. / Maslen, Cheryl; Babcock, Darcie; Redig, Jennifer K.; Kapeli, Katannya; Akkari, Yassmine M.; Olson, Susan.

In: Gene, Vol. 382, 01.11.2006, p. 111-120.

Research output: Contribution to journalArticle

Maslen, Cheryl ; Babcock, Darcie ; Redig, Jennifer K. ; Kapeli, Katannya ; Akkari, Yassmine M. ; Olson, Susan. / CRELD2 : Gene mapping, alternate splicing, and comparative genomic identification of the promoter region. In: Gene. 2006 ; Vol. 382. pp. 111-120.
@article{e3165dfc28ce444fadb9ef0d4b5c29ee,
title = "CRELD2: Gene mapping, alternate splicing, and comparative genomic identification of the promoter region",
abstract = "CRELD2 is the second member of the CRELD family of proteins. The only other CRELD family member, encoded by CRELD1, is also known as the AVSD2 gene as mutations in CRELD1 are associated with cardiac atrioventricular septal defects (AVSD). Like CRELD1, CRELD2 is ubiquitously expressed during development and by mature tissues. Recently, a specific CRELD2 isoform (CRELD2β) was implicated as a regulator of α4β2 nicotinic acetylcholine receptor expression, suggesting that the CRELD family has widely diverse biological roles in both developmental events and subsequent cell function. Here we report additional characterization of CRELD2, which was undertaken to further our understanding of this important family. Mapping of CRELD2 by FISH shows that it maps to 22q13 rather than the GenBank reported locus of 22p13. Comparative genomic analysis of upstream sequences shows a discrete region that is highly conserved among diverse species with hallmark features indicative of a promoter region. Functional analysis demonstrates that this region has promoter activity. Consistent with widespread expression of CRELD2, this region is GC-rich and lacks a TATA box. Overall, the highest levels of CRELD2 expression occur in adult endocrine tissues. However, alternative splicing of CRELD2 is extensive with positive identification of several splice variants expressed by most normal fetal and adult tissues. Confirmed splice variants encode 5 different CRELD2 isoforms that differ significantly in composition indicating that CRELD2 function is varied and as yet poorly understood.",
keywords = "AVSD2, Congenital heart defects, CRELD1, Endocrine system, Nicotinic acetylcholine receptor",
author = "Cheryl Maslen and Darcie Babcock and Redig, {Jennifer K.} and Katannya Kapeli and Akkari, {Yassmine M.} and Susan Olson",
year = "2006",
month = "11",
day = "1",
doi = "10.1016/j.gene.2006.06.016",
language = "English (US)",
volume = "382",
pages = "111--120",
journal = "Gene",
issn = "0378-1119",
publisher = "Elsevier",

}

TY - JOUR

T1 - CRELD2

T2 - Gene mapping, alternate splicing, and comparative genomic identification of the promoter region

AU - Maslen, Cheryl

AU - Babcock, Darcie

AU - Redig, Jennifer K.

AU - Kapeli, Katannya

AU - Akkari, Yassmine M.

AU - Olson, Susan

PY - 2006/11/1

Y1 - 2006/11/1

N2 - CRELD2 is the second member of the CRELD family of proteins. The only other CRELD family member, encoded by CRELD1, is also known as the AVSD2 gene as mutations in CRELD1 are associated with cardiac atrioventricular septal defects (AVSD). Like CRELD1, CRELD2 is ubiquitously expressed during development and by mature tissues. Recently, a specific CRELD2 isoform (CRELD2β) was implicated as a regulator of α4β2 nicotinic acetylcholine receptor expression, suggesting that the CRELD family has widely diverse biological roles in both developmental events and subsequent cell function. Here we report additional characterization of CRELD2, which was undertaken to further our understanding of this important family. Mapping of CRELD2 by FISH shows that it maps to 22q13 rather than the GenBank reported locus of 22p13. Comparative genomic analysis of upstream sequences shows a discrete region that is highly conserved among diverse species with hallmark features indicative of a promoter region. Functional analysis demonstrates that this region has promoter activity. Consistent with widespread expression of CRELD2, this region is GC-rich and lacks a TATA box. Overall, the highest levels of CRELD2 expression occur in adult endocrine tissues. However, alternative splicing of CRELD2 is extensive with positive identification of several splice variants expressed by most normal fetal and adult tissues. Confirmed splice variants encode 5 different CRELD2 isoforms that differ significantly in composition indicating that CRELD2 function is varied and as yet poorly understood.

AB - CRELD2 is the second member of the CRELD family of proteins. The only other CRELD family member, encoded by CRELD1, is also known as the AVSD2 gene as mutations in CRELD1 are associated with cardiac atrioventricular septal defects (AVSD). Like CRELD1, CRELD2 is ubiquitously expressed during development and by mature tissues. Recently, a specific CRELD2 isoform (CRELD2β) was implicated as a regulator of α4β2 nicotinic acetylcholine receptor expression, suggesting that the CRELD family has widely diverse biological roles in both developmental events and subsequent cell function. Here we report additional characterization of CRELD2, which was undertaken to further our understanding of this important family. Mapping of CRELD2 by FISH shows that it maps to 22q13 rather than the GenBank reported locus of 22p13. Comparative genomic analysis of upstream sequences shows a discrete region that is highly conserved among diverse species with hallmark features indicative of a promoter region. Functional analysis demonstrates that this region has promoter activity. Consistent with widespread expression of CRELD2, this region is GC-rich and lacks a TATA box. Overall, the highest levels of CRELD2 expression occur in adult endocrine tissues. However, alternative splicing of CRELD2 is extensive with positive identification of several splice variants expressed by most normal fetal and adult tissues. Confirmed splice variants encode 5 different CRELD2 isoforms that differ significantly in composition indicating that CRELD2 function is varied and as yet poorly understood.

KW - AVSD2

KW - Congenital heart defects

KW - CRELD1

KW - Endocrine system

KW - Nicotinic acetylcholine receptor

UR - http://www.scopus.com/inward/record.url?scp=33749597022&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33749597022&partnerID=8YFLogxK

U2 - 10.1016/j.gene.2006.06.016

DO - 10.1016/j.gene.2006.06.016

M3 - Article

VL - 382

SP - 111

EP - 120

JO - Gene

JF - Gene

SN - 0378-1119

ER -